Cannabis, or marijuana, the most commonly used illicit drug in the world, has been shown to be responsible for suppressing the production and secretion of androgens, particularly testosterone. However, despite such findings in animals, the chronic effects of marijuana use on human endocrine systems have proved to be inconsistent. Here, we investigated the reference ranges of urinary levels of testosterone (T) and epitestosterone (E) as well as their metabolic ratio of T/E in a Korean male population (n = 337), which would enable an evaluation of abnormal changes in steroid metabolism induced by habitually administered cannabis. The T/E ratio was significantly decreased in the marijuana group (n = 18), while the urinary testosterone concentrations were also tended to decrease. This study is the first to provide data for the reference values of two urinary androgens and T/E values among control Korean males, and, furthermore, suggests that the T/E ratio, though not testosterone levels, might be used to understand the suppression of human male gonadal function affected by smoking marijuana.
Introduction
Cannabis, or marijuana, is the most commonly used illicit drug in the world. It contains at least 61 cannabinoids, of which 9 -tetrahydrocannabinol (THC) is the primary psychoactive ingredient [1] . Although THC-based drugs for the treatment of pain and nausea are already FDA approved and prescribed, the endocrine properties of marijuana have only been investigated since the 1970s [2] . The clinical impacts of marijuana on endocrine systems, including the gonadal, adrenal, prolactin, growth hormone, and thyroid hormone systems, in experimental models have been reported [3] [4] [5] . In particular, the chronic use of cannabinoids significantly suppresses the production and secretion of androgens, notably testosterone in vitro and in vivo [6] [7] [8] . However, there is conflicting evidence that the use of cannabinoids in humans has little effect on the metabolic fate of testosterone [3, 5, [9] [10] [11] .
The urinary T/E ratio, i.e., the ratio of testosterone (T) to epitestosterone (E; a naturally occurring 17␣-epimer of T), has been used to determine exogenous administration or abnormally high testosterone levels because the T/E value does not vary within an individual and shows little inter-individual variation [12] . The interconversion between testosterone and epitestosterone in humans is negligible. Further, the concentration of epitestosterone is not affected by the intake of testosterone [13] [14] [15] . Therefore, change in the urinary T/E ratio in humans is of great interest in doping control because it is affected by various drugs and nutritional supplements [16] [17] [18] . However, no metabolic associations between the T/E ratio and habitual marijuana use have been reported to date.
The biological actions of testosterone in androgen-dependent neoplasms and healthy conditions vary considerably across racial/ethnic groups [19] [20] [21] . The T/E ratio in Caucasian athletes shows a median value of 1.1, and was 5.6 or less in 99% of the male athletes, whereas in Korean populations, the median value was 0.15 [22, 23] . In the present study, we examined the urinary levels of testosterone and epitestosterone, as well as T/E ratios, in Korean male marijuana abusers compared with those in drug-free controls in an attempt to determine whether marijuana has an effect on endogenous steroid metabolism.
Experimental

Materials
Reference standards of testosterone and epitestosterone were obtained from Sigma (St. Louis, MO, USA). THC-COOH was purchased from Cerilliant (Round Rock, TX, USA). The internal standards, d 3 -testosterone, d 3 -epitestosterone, and d 9 -11-nor-9-carboxy-9 -tetrahydrocannabinol (THC-COOH-d 9 ), were obtained from C/D/N Isotopes (Pointe-Claire, Quebec, Canada) and Cerilliant. Sodium acetate (reagent grade, anhydrous) and sodium phosphate dibasic were also purchased from Sigma. For enzymatic hydrolysis, a 50% glycerol solution of ␤-glucuronidase from Escherichia coli (140 U/mL) was supplied by Roche (Mannheim, Germany) and an Oasis HLB cartridge (3 mL, 60 mg) for solid-phase extraction (SPE) was obtained from Waters (Milford, MA, USA). The derivatizing agents N-methyl-N-trifluorotrimethylsilyl acetamide (MSTFA), ammonium iodide (NH 4 I), and dithioerythritol (DTE) were purchased from Sigma. All organic solvents were of HPLC grade and supplied by J. T. Baker (Phillipsburg, NJ, USA). The water was purified using a Direct-Q water purification system (Millipore, Bedford, MA, USA).
Subjects
Study subjects included two groups: 18 male marijuana users aged from 24 to 57 years (mean 40.2 ± 9.9 years), and 337 drug-free male aged from 22 to 52 years (mean 30.3 ± 5.4 years) as the marijuana non-users. Urine samples of the marijuana user as habitual drug offenders (>6 months) and non-user groups were collected at the Narcotics Departments of the District Prosecutors' Offices (Seoul, South Korea) and at the Doping Control Center (Seoul, South Korea), respectively. The study was approved by the Ethics Committee of the Forensic Science Planning Office at the Supreme Prosecutors' Office, and informed consent (written or oral) was obtained from each participant before collecting the urine samples.
Sample preparation
Sample preparations for quantification of the T/E ratio and THC-COOH were based on previous reports [24, 25] . Briefly, urine samples (2 mL) spiked with 20 L of two internal standards (d 3 -testosterone and d 3 -epitestosterone; 1 g/mL) were extracted with Oasis HLB TM SPE cartridges coupled to a peristaltic pump. After loading a sample onto a cartridge, the cartridge was washed with 2 mL water and eluted twice with 2 mL of methanol. Combined methanol eluates were evaporated under a stream of nitrogen and then 1 mL of 0.2 M acetate buffer (pH 7.2) and 50 L of ␤-glucuronidase were was added. After incubation at 55 • C for 1 h, the solution was extracted twice with 2.5 mL of ethylacetate:n-hexane (2:3, v/v). The combined organic solvent extracts were evaporated using an N 2 evaporator at 40 • C and further dried in a vacuum desiccator over P 2 O 5 -KOH for at least 30 min. Finally, the dried residue was derivatized with MSTFA/NH 4 I/DTE (40 L; 500:4:2, v/w/w) at 60 • C for 20 min and 2 L of the resulting mixture was subjected to gas chromatography-mass spectrometry (GC-MS) in selected-ion monitoring (SIM) mode.
For THC-COOH quantification, urine samples (2 mL) were spiked with 20 L of internal standard (THC-COOH-d 9 ; 1 g/mL) in 1 mL of phosphate buffer (0.2 M, pH 7.2), and then incubated with 50 L of ␤-glucuronidase for 1 h at 55 • C. The Oasis HLB SPE cartridges were placed in a device fitted with a small peristaltic pump and each was washed with 2 mL water and eluted twice with 1.5 mL of methanol. The combined methanol eluates were evaporated under a stream of nitrogen, and residues were further dried in a vacuum desiccator over P 2 O 5 -KOH for 30 min. Dried extracts were trimethylsilylated and then analyzed in the GC-SIM/MS.
Instrumental analysis
GC-MS analysis was carried out using an Agilent 6890 Plus gas chromatograph interfaced with a single-quadrupole Agilent 5975 MSD. The electron energy was 70 eV and the ion source temperature was 230 • C. Each sample (2 L) was injected in split mode (10:1) at an injector temperature of 280 • C and separated by passing through an Ultra-1 capillary column (25 m × 0.2 mm i.d., 0.33 m film thickness; Agilent Technologies, Palo Alto, CA). The oven temperature was initially 215 • C, which was ramped to 260 • C at 1 • C/min, and then finally increased to 320 • C (held for 1 min) using a 15 • C/min ramping program. Ultra-high purity helium was used as the carrier gas with a column head pressure of 210.3 kPa (column flow: 1.0 mL/min at an oven temperature of 215 • C).
Urinary THC-COOH was chromatographed through an Ultra-2 capillary column (25 
Statistical analysis
Data manipulation was performed using Sigmaplot (SYSTAT Software Inc., San Jose, CA) and an SPSS (v. 21) for Windows (SPSS Inc, Chicago, IL) software package. Statistical analysis was preceded by the Shapiro-Wilk test for normality calculates the probability that the sample was drawn from a normal population. According to its normality, the concentrations of testosterone (T) and epitestosterone (E) and the T/E ratio in the urine samples obtained from male marijuana users and control male subjects were compared using a non-parametric Mann-Whitney U-test. Also, correlations between variables were tested using a non-parametric Spearman's rho correlation coefficient. P-values <0.05 were considered statistically significant.
Median, mean, standard deviation, minimum, maximum, and quartiles were used as descriptive statistics for reference distributions. Outliers (Y) were identified according to Tukey's rule based on the following equations:
Y < (Q1 -1.5IQR) or Y > (Q3 + 1.5IQR), where Q1 denotes the lower quartile (the 25th percentile), Q3 denotes the upper quartile (the 75th percentile), and IQR = (Q3 -Q1) denotes the interquartile range [26] .
Results
Reference levels of urinary testosterone and epitestosterone in Korean males
In this study, 337 Korean drug-free male with a mean age of 30 years (range: 22 to 52 years) were investigated (Fig. 1A) to determine healthy reference values of testosterone and epitestosterone, which could contribute to better understand the different incidence of some androgen-dependent pathologies between ethnical groups. The mean, median, first (IQ1) and third (IQ3) quartiles, and minimum and maximum values for urinary testosterone and epitestosterone concentrations and the T/E ratio are presented in Frequency distribution of age (A) and urinary T/E ratio (B) in a healthy Korean male population. The number of frequency is shown along the y-axis with the age and T/E ratio shown on the x-axis. The number of subjects in the sample is 337, while the median values of age and T/E ratio are 30 yr and 1.287, respectively.
Table 1
Reference ranges for urinary concentrations and ratio of testosterone (T) and epitestosterone (E) in a control male Korean population (n = 337). Concentrations of T and E are expressed as ng/mL, and T/E ratio is presented as the ratio of testosterone/epitestosterone in each subject.
Table 2
Comparison of urinary concentrations and ratio of testosterone (T) and epitestosterone (E) between control subjects and marijuana users in a Korean male population.
Age (yr.) Control subjects Marijuana users P-value n T (ng/mL) E (ng/mL) T/E ratio n T (ng/mL) E (ng/mL) T/E ratio T E T/E Results are medians with the 25th and 75th percentiles as interquartile range in parentheses. P values were determined by a non-parametric Mann-Whitney U-test between control subjects and marijuana users according to their normality results, and were set the significant level at 0.05 that is underlined. Table 1 . In the population of healthy Korean males examined in this study, the overall concentrations of testosterone appeared to be slightly higher than those of epitestosterone (P = 0.026); however, the urinary ranges of the 25/75th percentiles showed similar excretion rates of testosterone and epitestosterone across all ages, which suggests that normal men have similar urinary levels of testosterone and epitestosterone (Table 2 ). In the frequency distributions of urinary T/E values, a mean T/E ratio of less than 2.0 was observed in 67.1% of all subjects (<1.0: 38.3%; <2.0: 28.8%), being between 0.15 and 5.46 within the 99% percentile cut-off level. Among the 337 male subjects, one had a urinary T/E ratio >6, which could be considered as the unusual metabolic ratio (Fig. 1B) . Therefore, this one outlier that exceeded the upper fence 1.5 (IQR) from the third quartile was removed from the dataset using the definition provided by John Tukey [26] . To ensure a reliable comparison between the marijuana user and control groups, 27 suspected outliers for testosterone were removed from the distributed datasets in the population of 337 drug-free males, and one outlier was removed from among the marijuana users (Table 3) . Table 3 Comparison of urinary concentrations and ratio of testosterone (T) and epitestosterone (E) between control subjects and marijuana users in a Korean male population after removing the outliers.
Age (yr.) Control subjects Marijuana users P-value n T (ng/mL) E (ng/mL) T/E ratio n T (ng/mL) E (ng/mL) T/E ratio T E T/E Results are medians with the 25th and 75th percentiles as interquartile range in parentheses. P values were determined by a non-parametric Mann-Whitney U-test between control subjects and marijuana users according to their normality results, and were set the significant level at 0.05 that is underlined.
Effects of marijuana use on urinary levels of testosterone and the T/E ratio
The urinary levels of two androgens in the control subjects were compared with those of 18 marijuana abusers who tested cannabispositive (≥15 ng/mL THC-COOH) [27] . In the marijuana users, the urinary concentrations of testosterone and epitestosterone were ≥70 ng/mL, and the median concentration of testosterone was approximately four times lower than that of epitestosterone ( Table 2) . The median testosterone level was 2.82 ng/mL, with the individual values ranging from 0.04 to 65.0 ng/mL (which included one outlier with a very high value) (data not shown). Although the testosterone value for one of the 18 marijuana users, which showed a large variation, was excluded from the analysis, the overall concentrations of testosterone appeared to be remarkably lower than those of epitestosterone (P < 0.003). The urinary concentrations of the two androgens and T/E ratio according to age-matched distribution were compared to provide an overview of the differences in their levels between marijuana users and control subjects (Table 3) . For the comparison, age was categorized as follows: 20 to 29, 30 to 39, and ≥40 years. The age-matched and total differences between marijuana users (n = 17) and non-users (n = 310) were evaluated using a non-parametric Mann-Whitney U test.
Compared to the control group, the overall median concentration of testosterone in marijuana abusers was observed to be considerably (more than 6-fold) lower (P < 0.000005). For agematched comparisons, however, the P values were statistically significant in only for subjects in their thirties, with decreased testosterone levels in marijuana group. No significant difference was found between the two groups for the other age categories, which may be due to the wide variation in individual responses to marijuana abuse. As a consequence, there was no correlation between the urinary testosterone concentrations and age-matched marijuana-smoking male users, as was also found for epitestosterone. The median values of the T/E ratio in the marijuana user and non-user groups were 0.191 and 1.287, respectively. Furthermore, the T/E ratio in all age categories was significantly lower in the marijuana group, regardless of whether outliers were removed or not (Tables 2 and 3 ). However, even though the T/E ratio differed markedly between the two groups, it was found that urinary testosterone levels in the marijuana users showed an overlap with the low values measured in the control group.
Discussion
In contrast to the information available relating to reference ranges for the urinary steroid profile in Caucasian and LatinAmerican populations [28, 29] , there has been only limited data that include reference ranges for a small number of subjects in a Korean population to date [23, 24, 30] . Because racial difference is one of the parameters associated with differences in steroid metabolism and androgen-dependent pathologies, reference values obtained from a healthy Korean population are necessary [29, 31] . Accordingly, in the present study, reference values for testosterone and epitestosterone, as well as the corresponding T/E ratio, were determined from a large Korean male population, thereby allowing the determination of abnormal values as an indicative tool for evaluating the abnormal steroid metabolism caused by marijuana. In control groups, testosterone levels tend to start declining at 40 years after maturation (Tables 2 and 3) , which may be due to andropause, which is characterized by an age-related gradual and progressive decline in testosterone levels to below the normal range found in young men [32] .
In general, the urinary excretion of epitestosterone in males is known to be nearly constant until the sixth decade of life [14, 15] .
In the present study, however, levels of epitestosterone in Korean men started to show a slight decline at age of 40 years and above (Tables 2 and 3 ). In addition, our results showed that there were no significant differences in the mean T/E ratio across all age categories, which is consistent with previous findings in adults [12] . Recently, the genetic variability of urinary T/E ratios has been reported [18, 23] . Compared with previous reports [28, 29, 31] , the lower androgen levels in Korean males than in Caucasian males may be explained by the fact that the pattern of testosterone excretion has been shown to be strongly correlated with a UGT2B17 (uridine diphosphoglucuronosyl transferase) deletion polymorphism, which is up-regulated in del/del genotype of Korean [23] . In addition, the distribution of T/E ratio values showed that the values were mostly less than 1, which may be due to the lower concentrations of testosterone glucuronide, which has been shown to be a characteristic of Asians [33] . To our knowledge, this is the first study to determine the reference values of testosterone and epitestosterone, and the corresponding T/E ratios, in a large healthy Korean male population, and we have shown that these values are useful for comparison with the respective estimated values.
Studies have shown that marijuana and its active component, THC, may have an impact on multiple endocrine systems, including gonadal, adrenal, prolactin, growth hormone, and thyroid hormone systems [3] [4] [5] . In particular, a suppressive effect has been observed on the gonadal steroids as reproductive hormones, along with activation of the hypothalamic-pituitary-adrenal (HPA) axis. The effects of cannabis on male sexual and reproductive function in animals results in a significant decrease in both testosterone and gonadotropin [6] [7] [8] . Although the effect of chronic exposure is less dramatic than that of acute treatment [8] , both acute and chronic THC administration in animals appears to cause a significant depression of testosterone release and gonadal function [3, 4] .
In contrast to the animal models, the effects of marijuana in humans have not been conclusively elucidated [9, 10] . Some studies have reported no effects on circulating testosterone, LH, or FSH levels in chronic marijuana users [10, 11] , whereas others have demonstrated that cannabis negatively affects male reproductive physiology, suggesting that chronic marijuana use could reduce the levels of circulating testosterone, FSH, and LH levels compared with those in controls who had never used marijuana [9, 34] . It has been suggested that reduced testosterone synthesis may be the result of the following THC effects: (1) the direct inhibition of androgen release from Leydig cells; (2) down-regulation of gonadotropin/luteinizing hormone (LH) or follicle-stimulating hormone (FSH) release from the anterior pituitary through a decrease in gonadotropin-releasing hormone (GnRH); or (3) down-regulation of cannabinoid (CB 1 ) receptor expression in the hypothalamus or testes [3] [4] [5] [6] 11] . These discrepancies among human studies may be due to differences in study design, but may also reflect the development of tolerance [3, 5] , and it is difficult to evaluate the endocrine effects of marijuana using only the extent of down-regulated urinary testosterone levels, as suggested by other previous studies.
In this study, the marijuana use in Korean males was shown to inhibit urinary excretion of testosterone; however, decreased levels of testosterone in the two investigated groups were detected only in participants in their thirties, showing no effects in the other agematched subjects (Table 2) . Therefore, estimates of testosterone excretion are of limited value for detecting cannabis misuse, which may be due to the large variation between individuals caused by differences in ethnicity, smoking habits, and body composition [20, 35] . Thus, it is important to evaluate androgen action by undertaking carefully designed studies that correct for parameters of additional influence, which could result in useful and fascinating Marijuana users (n=18 ) Fig. 2 . Comparison of the urinary ratio of testosterone (T) and epitestosterone (E) in 337 control subjects and 18 marijuana users. The median values of the T/E ratio were 0.191 and 1.287 in the marijuana user and non-user groups, respectively, and the difference was found to be significant (P < 1.6 × 10 -7 ).
information regarding the association between marijuana abuse and testosterone levels. Interestingly, the urinary T/E ratio, although not the testosterone level, indicates the existence of a relationship between marijuana use and depression of male gonadal steroids, regardless of age. There are however, certain limitations to the present study, notably the small number of marijuana smokers investigated (only 18 males), which could limit the statistical power to detect weak associations and effects related to marijuana use. However, even with this limitation, we suggest that the urinary T/E ratio may prove to be a better indicator for evaluation of metabolic changes in gonadal functions caused by marijuana abuse in Korean males (Fig. 2) . In addition, the correlation between T/E levels and the THC-COOH concentrations in both drug-free control and marijuana user groups were evaluated (Supplementary Table 1 ). The concentrations of testosterone and epitestosterone are negatively correlated with the age in control group, while no variables are correlated in marijuana users. Further studies are required to confirm the possible associations between exposure to marijuana and the endocrine system in hormonal regulation among Korean populations, as well as in Caucasian populations.
Although the creatinine correction could be often influenced by time of day, age, sex, race/ethnicity, diet, body mass, and activity level, our results might not be convinced of the results regarding the individual concentrations of testosterone and epitestosterone without consideration for dilution of urine samples.
Conclusions
For the first time, reference values for urinary testosterone and epitestosterone levels, which can calculate the T/E ratio, in a large Korean male population, which may allow the evaluation of abnormal steroid metabolism, have been investigated. An association between marijuana smoking and urinary androgen levels was detected; however, this appeared to be an age-specific effect. In addition, the habitual marijuana smokers have lower T/E ratios, a finding that supports the hypothesis of depression of male gonadal steroids after cannabis use. It can be speculated that the T/E ratio rather than testosterone levels could be used as a potential parameter for indicating the suppression of male gonadal function after smoking marijuana.
